Renaissance Technologies’s Mirum Pharmaceuticals MIRM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $20.2M | Buy |
396,348
+207,848
| +110% | +$10.6M | 0.03% | 712 |
|
2025
Q1 | $8.49M | Buy |
188,500
+87,252
| +86% | +$3.93M | 0.01% | 1095 |
|
2024
Q4 | $4.19M | Buy |
101,248
+40,800
| +67% | +$1.69M | 0.01% | 1558 |
|
2024
Q3 | $2.36M | Buy |
+60,448
| New | +$2.36M | ﹤0.01% | 1909 |
|
2024
Q1 | – | Sell |
-58,648
| Closed | -$1.73M | – | 3933 |
|
2023
Q4 | $1.73M | Sell |
58,648
-10,052
| -15% | -$297K | ﹤0.01% | 2047 |
|
2023
Q3 | $2.17M | Buy |
68,700
+57,100
| +492% | +$1.8M | ﹤0.01% | 1816 |
|
2023
Q2 | $300K | Sell |
11,600
-2,000
| -15% | -$51.7K | ﹤0.01% | 3120 |
|
2023
Q1 | $327K | Sell |
13,600
-79,700
| -85% | -$1.92M | ﹤0.01% | 3073 |
|
2022
Q4 | $1.82M | Buy |
+93,300
| New | +$1.82M | ﹤0.01% | 2132 |
|
2022
Q3 | – | Sell |
-41,500
| Closed | -$808K | – | 4277 |
|
2022
Q2 | $808K | Buy |
41,500
+8,300
| +25% | +$162K | ﹤0.01% | 2850 |
|
2022
Q1 | $731K | Buy |
33,200
+4,800
| +17% | +$106K | ﹤0.01% | 2936 |
|
2021
Q4 | $453K | Sell |
28,400
-6,900
| -20% | -$110K | ﹤0.01% | 3121 |
|
2021
Q3 | $703K | Sell |
35,300
-14,100
| -29% | -$281K | ﹤0.01% | 2733 |
|
2021
Q2 | $854K | Buy |
+49,400
| New | +$854K | ﹤0.01% | 2741 |
|
2021
Q1 | – | Sell |
-42,900
| Closed | -$749K | – | 3559 |
|
2020
Q4 | $749K | Buy |
+42,900
| New | +$749K | ﹤0.01% | 2641 |
|
2020
Q3 | – | Sell |
-13,000
| Closed | -$253K | – | 3558 |
|
2020
Q2 | $253K | Buy |
+13,000
| New | +$253K | ﹤0.01% | 3099 |
|